Studies on the specificity of the complement fixation test in cytomegalovirus infections. With special reference to possible cross-reactions with other herpesvirus antigens.

AbstractComplement fixation tests with cytomegalovirus, herpesvirus hominis and varicella-zoster virus antigens and immunofluorescence test with Epstein-Barr virus antigens have been performed on two or more sera from 36 patients infected with one or more of these viruses. In 23 patients only a homologous rise in antibodies was registered, whereas 6 patients had rising titres against 2 or more viruses. In 4 instances the well-known cross reaction between herpesvirus hominis and varicella-zoster virus was seen. The findings in 3 patients of a simultaneous rise in antibodies against cytomegalovirus and one or two of the other antigens employed could be explained on the basis of a double infection with cytomegalovirus and herpesvirus hominis. The present findings support the view that the complement fixation test for cytomegalovirus antibodies possesses a high degree of specificity and can therefore be used diagnostically.

[1]  O. Marker Fluorescent EBV antibodies in infectious mononucleosis. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[2]  H. Andersen,et al.  Clinically Evident, Non-terminal Infections with Herpesviruses and the Wart Virus in Immunosuppressed Renal Allograft Recipients , 1970, British medical journal.

[3]  C. Joyner,et al.  Antibody responses to the Epstein-Barr virus and cytomegaloviruses after open-heart and other surgery. , 1970, The New England journal of medicine.

[4]  H. Andersen,et al.  Cytomegalovirus infection among renal allograft recipients. , 2009, Acta medica Scandinavica.

[5]  J. B. Hanshaw Congenital cytomegalovirus infection: laboratory methods of detection. , 1969, The Journal of pediatrics.

[6]  E. H. Lennette,et al.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests. , 1969, The Journal of general virology.

[7]  B. Wahrén,et al.  Serological studies on cytomegalovirus infection in relation to infectious mononucleosis and similar conditions. , 1969, Scandinavian journal of infectious diseases.

[8]  L. Holmberg,et al.  Acquired cytomegalovirus infection. , 1968, British medical journal.

[9]  D. Calafiore,et al.  Experience with a human cytomegalovirus complement fixing antigen. , 1967, American journal of epidemiology.

[10]  D. Rifkind,et al.  The clinical significance of cytomegalovirus infection in renal transplant recipients. , 1967, Annals of internal medicine.

[11]  W. Henle,et al.  Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.

[12]  V. Vonka,et al.  Human cytomegalovirus: properties of the complement-fixing antigen. , 1966, Journal of immunology.

[13]  C. Ross,et al.  Antigenic relationship of varicella-zoster and herpes simplex. , 1965, Lancet.

[14]  D. Rifkind Cytomegalovirus infection after renal transplantation. , 1965, Archives of internal medicine.

[15]  R. Betts,et al.  ACQUIRED CYTOMEGALOVIRUS INFECTION: ASSOCIATION WITH HEPATOMEGALY AND ABNORMAL LIVER-FUNCTION TESTS. , 1965, The New England journal of medicine.

[16]  E. H. Lennette,et al.  A Complement-Fixing Antigen for Varicella-Zoster Derived from Infected Cultures of Human Fetal Diploid Cells.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  F. Rapp,et al.  Plaque assay for measurement of cells infected with zoster virus. , 1963, Science.

[18]  L. Hayflick,et al.  The serial cultivation of human diploid cell strains. , 1961, Experimental cell research.

[19]  R. Huebner,et al.  Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.